MedPath

A scientific study to assess prevalence of metabolic syndrome (MetS) in the cisgender-heterosexual, cisgender-sexual minority, transgender-heterosexual, and transgender-sexual minority subjects.

Not Applicable
Registration Number
CTRI/2021/03/031843
Lead Sponsor
Dr Rajiv Kovil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Individuals who are able and willing to give written informed consent

2. Individuals must be aged >=18 years at the time of screening

3. Individuals who are willing to identify their gender identity and sexual orientation

4. Individuals who are willing and able to comply with scheduled visits, laboratory tests and other study procedures

Exclusion Criteria

1. Individuals who are unwilling to complete a survey

2. Individuals unwilling to follow the study requirements

3. Individuals who are on pharmacotherapy for individual components of MetS

4. Pregnant and lactating individuals

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find the prevalence of MetS and itâ??s componentsTimepoint: Single Visit
Secondary Outcome Measures
NameTimeMethod
ot ApplicableTimepoint: Not Applicable
© Copyright 2025. All Rights Reserved by MedPath